FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products... Show more
FutureFuel Corp. is a manufacturer of custom and performance chemicals and biofuels, operating through two segments: Chemicals and Biofuels. Its chemicals business produces specialty and custom-manufactured products used in coatings, industrial and consumer cleaning, oil and gas, specialty polymers, and other industrial applications. The Biofuels segment manufactures and markets biodiesel, along with biodiesel-petrodiesel blends and related byproducts.
The company's manufacturing complex in Batesville, Arkansas, supports long-standing customer relationships, and management has highlighted reshoring demand from cost-advantaged U.S. production as a competitive theme. Investors follow the stock for its exposure to renewable fuels regulation, chemical manufacturing utilization, and its history of returning capital to shareholders through dividends and buybacks.
Over the last 30 days, FF shares have fallen approximately 46%, declining from a closing price of $5.21 on October 13, 2026, to about $2.80 in mid-November. Most of that move occurred in a single trading session, when the stock dropped roughly 38% from $5.07 to $3.12 immediately after the company reported third-quarter results.
The picture over the last quarter is similarly negative. From a closing level of $5.85 in mid-August, the shares have lost more than 50%, reflecting a multi-month retracement of the rally that followed second-quarter results. The broader trend shows a stock that spiked in early August, drifted steadily lower through September and October, and then accelerated to the downside following the November earnings release.
The dominant catalyst was FutureFuel's third-quarter 2026 earnings report, released after the market close on November 9. Revenue surged roughly 361% year over year to about $104.7 million, driven by stronger biofuel pricing and volume. However, the company still posted a GAAP loss of $0.19 per share, and the stock fell sharply on heavy volume the following session.
The loss reflected several factors. In the Biofuels segment, higher utilization and sales volume were offset by elevated feedstock costs and derivative losses, resulting in a segment gross loss. In the Chemicals segment, extended maintenance turnarounds at two dedicated customer production units reduced sales volume by 27% compared with the prior-year period and cut third-quarter Adjusted EBITDA by roughly $4.3 million. Together, these factors outweighed the top-line growth and triggered a sharp repricing of the shares.
The quarterly trend has been shaped by a shift in investor expectations. Shares rallied in early August after second-quarter results showed a return to profitability, with revenue growth and improved capacity utilization. Since then, sentiment has cooled as investors weighed thinner margins, the reduced $0.01 quarterly dividend, and lingering concerns about biofuel profitability.
The November selloff crystallized those concerns. Management pointed to strong fourth-quarter biodiesel bookings and a January 1, 2027, regulatory change that could narrow the competitive advantage of renewable diesel producers, but near-term results remain loss-making. The combination of an improved but still challenging operating backdrop and the dividend reduction has kept the stock under sustained pressure through the quarter.
Tickeron's Trending AI Robots page showcases a curated selection of automated trading strategies drawn from a broader platform that offers hundreds of AI trading bots covering thousands of tickers. Only top-performing and currently relevant bots appear in this section, helping users filter through a large and diverse universe of strategies. These bots vary in approach, holding period, and performance metrics, ranging from short-term momentum models to longer-horizon trend-following systems. For traders and investors looking to complement their own research with data-driven, systematic tools, the page provides a convenient starting point to review and compare available automated strategies.
Several factors are likely to shape FutureFuel's outlook. Investors will monitor whether fourth-quarter results translate the company's strong biodiesel booking visibility into improved margins, and whether the expected sale of roughly 1.5 million RINs and the recovery of derivative losses support profitability. The January 1, 2027, regulatory equivalency change for renewable fuels could improve the competitive position of biodiesel relative to renewable diesel.
On the chemicals side, the resumption of normal order cadence from key customers and the completion of maintenance work are important operational checkpoints. Management has also cited a $41 million customer-funded capital investment at Batesville between 2026 and 2028. Broader risks include feedstock cost volatility, derivative exposure, and continued margin pressure across both segments.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
FF's Aroon Indicator triggered a bullish signal on November 06, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 193 similar instances where the Aroon Indicator showed a similar pattern. In 147 of the 193 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 76%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where FF advanced for three days, in 193 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
FF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FF as a result. In 58 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for FF turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 29 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
FF moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for FF crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.524) is normal, around the industry mean (2.284). P/E Ratio (-8.867) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (1.548). Dividend Yield (0.008) settles around the average of (0.039) among similar stocks. P/S Ratio (1.553) is also within normal values, averaging (48.960).
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. FF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of specialty chemicals and biofuels
Industry ChemicalsSpecialty